Nesina

Chemical Namealogliptin
Dosage FormTablet (oral; 6.25mg, 12.5mg, 25mg)
Drug ClassInhibitors
SystemEndocrine
CompanyTakeda Pharmaceutical Company Limited
Approval Year2013

Indication

  • Used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Last updated on 4/28/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Nesina (alogliptin) Prescribing Information2013Takeda Pharmaceuticals America, Inc. Deerfield, IL